01/20/2014 | Mark Hillen
While other pharmaceutical companies are buying into ophthalmology, Pfizer is heading for the hills
12/04/2013
Who should receive ILUVIEN® for the treatment of chronic DME-associated vision impairment
12/04/2013 | Marianne Shahsuvaryan
The last decade has seen some great advances, but there's still room for improvement…
12/04/2013 | Sebastian Waldstein
Predicting treatment outcomes manages their expectations and improves your care.
12/02/2013 | Mark Hillen
If you had VMT or MH and could avoid vitrectomy, you would. Might ocriplasmin let you?
Bayer and Regeneron have presented the phase III trial data for aflibercept treatment of myopic choroidal neovascularization
An iPhone, an app, and a 20 D lens, along with a bit of practice, will get you fundus photographs in a pinch
12/02/2013 | Richard Gallagher
Two studies have found a link between long-term usage of contraceptive pills and glaucoma
Analysis of a rich long-term epidemiological dataset reveals that interventions have significantly reduced the probability of open-angle glaucoma-related blindness
10/29/2013 | Florian Gekeler
Can transcorneal electrical stimulation help reverse retinal degeneration in retinitis pigmentosa? Ongoing clinical trials suggest that it may.
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Redressing Representation
Living with TED: My Race from Patient to Advocate
How Dry Eye Disease Impacts Younger Patients
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: